Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,035B 10.91B 9.73B 9.01B 8.19B 15.37B 15.63B 108B 42.5B 541B 40.94B 40.08B 1,729B P/E 2027 *
28.1x
P/E 2028 * 21.5x
Enterprise Value 1,003B 10.57B 9.43B 8.73B 7.94B 14.9B 15.14B 105B 41.19B 524B 39.68B 38.85B 1,675B EV / Sales 2027 *
2.85x
EV / Sales 2028 * 2.5x
Free-Float
69.69%
Yield 2027 *
0.61%
Yield 2028 * 0.68%
1 day+0.82%
1 week+0.93%
Current month+0.49%
1 month+6.05%
3 months+2.57%
6 months+0.53%
Current year-2.29%
1 week 1,207.85
Extreme 1207.85
1,245
1 month 1,166.75
Extreme 1166.75
1,252
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 2019-06-30
Director of Finance/CFO - 2024-07-31
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 2014-05-12
Chairman 65 2013-04-01
Director/Board Member 65 2018-10-24
Date Insider Type Main position Quantity % Market Cap. Importance
4/1/26 Other

Global Head of Quality and PV

35,600 0.0043% -
12/18/25 Other

Chairman

85,738,125 10.2732%
12/18/25 Other

Director

12,717,090 1.5238%
Change 5-day change 1-year change 3-year change Capi.($)
+0.82%+0.93%-1.11%+10.41% 10.81B
-1.33%+4.88%+54.50%+109.94% 1,120B
-0.69%-3.77%+31.35%+66.62% 616B
-0.96%+0.55%+23.13%+94.26% 504B
+0.24%+5.58%+33.98%+59.40% 367B
-1.59%-1.25%+69.39%+43.02% 360B
-0.40%+3.53%+19.17%+46.55% 288B
-0.37%+3.11%-1.26%+18.23% 258B
-1.75%+1.76%+42.21%+51.44% 234B
-2.00%+1.75%+24.64%+95.14% 194B
Average -0.80%+2.38%+29.60%+59.50% 395.17B
Weighted average by Cap. -0.98%+2.42%+37.79%+75.34%

Financials

2027 *2028 *
Net sales 352B 3.71B 3.31B 3.07B 2.79B 5.23B 5.32B 36.76B 14.46B 184B 13.93B 13.64B 588B 393B 4.15B 3.7B 3.42B 3.11B 5.84B 5.94B 41.07B 16.15B 205B 15.56B 15.23B 657B
Net income 36.53B 385M 343M 318M 289M 543M 552M 3.82B 1.5B 19.09B 1.45B 1.42B 61.04B 48.57B 512M 457M 423M 385M 722M 734M 5.07B 2B 25.39B 1.92B 1.88B 81.15B
Net Debt -31.96B -337M -300M -278M -253M -475M -483M -3.34B -1.31B -16.7B -1.26B -1.24B -53.39B -51.37B -542M -483M -447M -407M -763M -776M -5.37B -2.11B -26.85B -2.03B -1.99B -85.82B
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
26-10-19 ₹1,242.00 +0.82% 26,188
26-10-16 ₹1,231.85 +0.91% 77,545
26-10-15 ₹1,220.75 +0.55% 112,661
26-10-14 ₹1,214.10 -2.06% 43,854
26-10-13 ₹1,239.65 +0.74% 125,767
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,242.00INR
Average target price
1,283.65INR
Spread / Average Target
+3.35%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Reddy's Laboratories Limited
  1. Stock Market
  2. Stocks
  3. DRREDDY Stock